1. Alterations of sodium-hydrogen exchanger 1 function in response to SGLT2 inhibitors: what is the evidence?

   • Surasak Wichaiyo
   • Nakkawee Saengklub

   ReviewPaper 18 February 2022 Pages: 1973 - 1990

   

2. Therapeutic augmentation of NO-sGC-cGMP signalling: lessons learned from pulmonary arterial hypertension and heart failure

   • Filippos Triposkiadis
   • Andrew Xanthopoulos
   • Randall C. Starling

   ReviewPaper 18 April 2022 Pages: 1991 - 2003

   

3. The cardiosplenic axis: the prognostic role of the spleen in heart failure

   • Hiroaki Hiraiwa
   • Takahiro Okumura
   • Toyoaki Murohara

   ReviewPaper Open access 18 May 2022 Pages: 2005 - 2015

   

4. Severe low-gradient aortic stenosis: impact of inadequate left ventricular responses to high afterload on diagnosis and therapeutic decision-making

   • Michael Dandel
   • Roland Hetzer

   ReviewPaper 16 April 2022 Pages: 2017 - 2031

   

5. Myocarditis following COVID-19 vaccination in adolescents and adults: a cumulative experience of 2021

   • Onyedika J. Ilonze
   • Maya E. Guglin

   ReviewPaper 22 April 2022 Pages: 2033 - 2043

   

6. Neuromuscular diseases and their cardiac manifestations under the spectrum of cardiovascular imaging

   • Georgios M. Alexandridis
   • Efstathios D. Pagourelias
   • Vassilios P. Vassilikos

   ReviewPaper 20 July 2022 Pages: 2045 - 2058

   

7. Cardiovascular disease associated with methamphetamine use: a review

   • Jared Tobolski
   • Douglas B. Sawyer
   • Maxwell Eyram Afari

   ReviewPaper 18 July 2022 Pages: 2059 - 2065

   

8. Predictors of fatal arrhythmic events in patients with non-compaction cardiomyopathy: a systematic review

   • George Bazoukis
   • Konstantinos Tyrovolas
   • Adrian Baranchuk

   ReviewPaper 01 July 2022 Pages: 2067 - 2076

   

9. Heart failure with a preserved ejection fraction and the EMPEROR-Preserved Trial: a review of how we got here

   • Tiago Tribolet de Abreu

   ReviewPaper 23 May 2022 Pages: 2077 - 2082

10. Ambulatory factors influencing pulmonary artery pressure waveforms and implications for clinical practice

    • Amit Alam
    • Rita Jermyn
    • Andrew J. Sauer

    ReviewPaper 19 May 2022 Pages: 2083 - 2093

    

11. The role of cardiac magnetic resonance in identifying appropriate candidates for cardiac resynchronization therapy — a systematic review of the literature

    • George Bazoukis
    • Jeremy Man Ho Hui
    • Panagiotis Korantzopoulos

    ReviewPaper 31 August 2022 Pages: 2095 - 2118

    

12. Atrial fibrillation-induced tachycardiomyopathy and heart failure: an underappreciated and elusive condition

    • Antonis S. Manolis
    • Theodora A. Manolis
    • Helen Melita

    OriginalPaper 23 March 2022 Pages: 2119 - 2135

    

13. Cardiorenal syndrome: long road between kidney and heart

    • Carolina Victoria Cruz Junho
    • Mayra Trentin-Sonoda
    • Marcela Sorelli Carneiro-Ramos

    ReviewPaper 08 February 2022 Pages: 2137 - 2153

    

14. Soluble ST2: a valuable prognostic marker in heart failure

    • Sugeevan Savarimuthu
    • Pavan Goel
    • Amer Harky

    ReviewPaper 27 June 2022 Pages: 2155 - 2164

    

15. Association between electrical and mechanical remodeling after cardiac resynchronization therapy: systematic review and meta-analysis of observational studies

    • David Pilecky
    • Gabor Z. Duray
    • Mate Vamos

    ReviewPaper 07 June 2022 Pages: 2165 - 2176

    

16. Is it time to revisit ICD indications?

    • Amin Yehya
    • Jonathan D. Davis
    • Nasrien E. Ibrahim

    ReviewPaper 26 January 2022 Pages: 2177 - 2179

17. Discussion of LBBP synchronization effects in HF patients with LBBB and comparison with BiV-CRT

    • Shigeng Zhang
    • Qijun Shan

    ReviewPaper 14 March 2022 Pages: 2181 - 2186

    

18. Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis

    • Paolo Morfino
    • Alberto Aimo
    • Michele Emdin

    ReviewPaper Open access 06 April 2022 Pages: 2187 - 2200

    

19. Outcomes of heart transplantation in cardiac amyloidosis: an updated systematic review

    • Sofia Lakhdar
    • Chandan Buttar
    • Most Sirajum Munira

    ReviewPaper 20 May 2022 Pages: 2201 - 2209

    

20. MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers

    • Fanyan Luo
    • Wei Liu
    • Haisong Bu

    ReviewPaper 25 March 2022 Pages: 2211 - 2221

    

21. The heart and gut relationship: a systematic review of the evaluation of the microbiome and trimethylamine-N-oxide (TMAO) in heart failure

    • Kelley M. Anderson
    • Erin P. Ferranti
    • Carolyn Miller Reilly

    ReviewPaper 21 June 2022 Pages: 2223 - 2249

    

22. Follistatin-like 1 and its paralogs in heart development and cardiovascular disease

    • Martin Horak
    • DeLisa Fairweather
    • Julie Bienertova-Vasku

    ReviewPaper 22 July 2022 Pages: 2251 - 2265